From: ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review
First author | Published date/country | Study design | Study population | ECMO pts./total pts. | Age of ECMO pts. (years) | PaO2/FIO2a (mmHg) | MV durationa (day) | ECMO duration (days) | Discharged Aliveb, n (%) |
---|---|---|---|---|---|---|---|---|---|
Huang C [27] | January 24, 2020/Wuhan, China | Prospective/single centre | Ward and ICU | 2 /41 | NA | NA | NA | NA | NA |
Chen N [53] | January 30, 2020/Wuhan, China | Retrospective/single centre | Ward and ICU | 3/99 | NA | NA | NA | NA | NA |
Wang D [28] | February 07, 2020/Wuhan, China | Retrospective/single centre | Ward and ICU | 4 /138 | NA | NA | NA | NA | NA |
Yang X [29] | February 21, 2020/Wuhan, China | Retrospective/single centre | ICU | 6 /52 | NA | NA | NA | NA | 1 (16.7%) |
Guan W [54] | February 28, 2020/China | Prospective/multicentre | Ward and ICU | 5/1099 | NA | NA | NA | NA | NA |
Zhou F [30] | March 9, 2020/Wuhan, China | Retrospective/multicentre | Ward and ICU | 3/191 | NA | NA | NA | NA | 0/3 (0%) |
Li X [55] | March 30, 2020/Shanghai, China | Retrospective/multicentre | ICU | 8/16 | 64.3 ± 17.6 | 66.1 ± 7.8 | 9.7 ± 5.7 | 27.1 ± 17.7 | 3/7f |
Chen R [56] | April 11, 2020/China | Retrospective/multicentre | Ward and ICU 575 hospitals | 171/1590 | NA | NA | NA | NA | NA |
ELSO registry [57] | April 22, 2020/ELSO centres | – | ECMO | 487 | 49 (41–56) | 75 (62–100)c | 90 (34–135) | 190 (118–280)d | 36/90 (40%)e |
EuroELSO survey [58] | April 18, 2020/19 countries | – | ECMO | 820 | 52.4 | NA | NA | NA | NAf |